Command Palette

Search for a command to run...

Clinical Trials · NCT01425580

Liraglutide and Heart Failure in Type 2 Diabetes

CompletedPhase 2Liraglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Thomas Nystrom
Enrollment
62
Start date
Jan 2012
Locations
2 sites, Sweden
Primary endpoint
Left ventricle longitudinal function and/or functional reserve during rest and/or after exercise using tissue Doppler echocardiography
View Liraglutide compound reference